Abound Wealth Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
DDPIC
WCM
HPCM
MCM
Abound Wealth Management's LH Position: Q2 2026 in Review
Abound Wealth Management reduced its Labcorp (LH) stake by 15% in Q2 2026, selling an estimated $4.21K and leaving 93 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #328.
Abound Wealth Management first reported a position in LH in Q3 2022 and has held it in 16 quarters since. The position peaked at $40.2K in Q3 2025. 287 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Abound Wealth Management held 93 shares of Labcorp worth $26.1K as of Q2 2026.
- Abound Wealth Management sold 16 Labcorp shares in Q2 2026, an estimated $4.21K.
- Labcorp made up 0.01% of Abound Wealth Management's portfolio in Q2 2026, its #328 holding.
- Abound Wealth Management first reported a position in Labcorp in Q3 2022 and has held it in 16 quarters since.
- Abound Wealth Management's Labcorp position peaked at $40.2K in Q3 2025.
- 287 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.